Using parental HL-60 cells and drug-resistant derivatives as the model, researchers found that acid ceramidase overexpression in HL-60 induced resistance to the AML chemotherapy drugs such as cytarabine, mitoxantrone, and daunorubicin [80]. The gene discussed is ASAH1; the disease is acute myeloid leukemia.